Shared on 29 Oct 25
Analysts have modestly lowered their price target for Hormel Foods to $34 from $36, citing weaker recent results and a cautious near-term outlook. However, they note there are some encouraging underlying trends.
Shared on 27 Aug 25
Fair value Decreased 11%Global Protein Consumption And Natural Health Will Fuel Expansion
Analysts have raised Hormel Foods’ price target modestly to $33.00, citing improved earnings outlook from Planters, stabilized turkey supply, ongoing cost savings, and attractive valuation supporting resilient long-term growth. Analyst Commentary Bullish analysts expect a recovery in Hormel’s earnings outlook, driven by improvements in the Planters business and a stabilized turkey supply situation.
Shared on 07 May 25
Fair value Increased 1.36%Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
Shared on 30 Apr 25
Fair value Increased 0.094%Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 16 Apr 25
Fair value Increased 1.88%Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 0.35%Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Decreased 2.54%Recovery Of Planters And Expansion In China Will Strengthen Future Prospects
AnalystConsensusTarget has increased revenue growth from 1.8% to 2.7%.